Skip to main content
Menu
US

AB-MECA, [125I]-(4-Amino-3-[125I]iodobenzyl-5`-N-)-, 10µCi

AB-MECA, labeled with 125I. AB-MECA acts as an agonist at adenosine A3 receptors, a group of GPCRs that are potential drug targets for immune-related disease, including rheumatoid arthritis, cancer, ischaemia, and inflammatory disease.

For research use only. Not for use in diagnostic procedures.

Feature Specification
Fresh Lot Days Second Monday of each month
Label Position Nominally Labeled
Molecular Weight 523
Receptor Adenosine

AB-MECA, labeled with 125I. AB-MECA acts as an agonist at adenosine A3 receptors, a group of GPCRs that are potential drug targets for immune-related disease, including rheumatoid arthritis, cancer, ischaemia, and inflammatory disease.

Product Variants
Unit Size: 10 µCi
Part #:
NEX312010UC
List Price
USD 2,141.00
Unit Size: 50 µCi
Part #:
NEX312050UC
List Price
USD 4,167.00

Overview

10 µCiQuantities of AB-MECA, [125I]-(4-Amino-3-[125I]iodobenzyl-5`-N-)- are available for your research.

We offer radioligands and radiolabeled biomolecules to use as tracers, for radioimmunoassays (RIAs), for autoradiographic visualization, or for performing saturation and competition radioligand binding assays to determine receptor expression levels (Bmax), dissociation constants (Kd), association and dissociation rates (kon and koff), and inhibitor constants (Ki) for a variety of receptors. We develop our radioligands to the highest specific activity possible and provide high purity resulting in low non-specific binding products. Each of our ultra-pure radiolabeled compounds is fully characterized for pharmacological action and validated in binding assays.

Radiochemicals remain the most sensitive method for probing binding biology; yielding unprecedented sensitivity gives results that technicians and scientists can trust. For over 50 years, Revvity has been a leading supplier of New England Nuclear (NEN) radiochemicals, liquid scintillation cocktails, vials and nuclear counting detection instruments.

References for NEX312:

  1. Haeusler, D., Grassinger, L., Fuchshuber, F. et al. (2015), Hide and seek: a comparative autoradiographic in vitro investigation of the adenosine A3 receptor, Eur J Nucl Med Mol Imaging, 42: 928-939.
  2. Ongini, E., Dionisotti, S., Gessi, S. et al. (1999), Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors, Naunyn-Schmiedeberg's Arch Pharmacol, 359: 7-10.

Specifications

Molecular Weight
523
Specific Activity
2200.0 Ci/mmol
Application
Drug Discovery & Development
Brand
NEN Radiochemicals
Buffer/Solvent
Methanol
Detection Modality
Radiometric
Fresh Lot Days
Second Monday of each month
Label Position
Nominally Labeled
Packaging
NENSure vial
Radioisotope
125I
Receptor
Adenosine
Shipping Conditions
Shipped Ambient
Special Ordering Information
This is a radioactive product - shipping address must have a license to receive radioactive materials.
Storage Conditions
4°C
Therapeutic Area
Cardiovascular
CNS & Neurologic
Inflammation
Metabolic Disorders
Unit Size
10 µCi

Resources

Are you looking for resources, click on the resource type to explore further.

1-3 of 3 Resources
Calendar Icon
Calendar
2024 Fresh Lot Calendar
Guide Icon
Guide
Iodine-125 handling precautions

This document contains general information designed to provide a basic understanding of radiation safety for Iodine-125. While we...

Flyer Icon
Flyer
NENSure: The safest packaging for radiochemicals

SDS, COAs, Manuals and more

Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.

Technical data sheet
+ Show more
Scroll Icon